Rapidly rising global rates of chronic diseases portend a consequent rise in ESRD. Despite this, kidney disease is not included in the list of noncommunicable diseases (NCDs) targeted by the United Nations for 25% reduction by year 2025. In an effort to accurately report the trajectory and pattern of global growth of maintenance dialysis, we present the change in prevalence and incidence from 1990 to 2010. Data were extracted from the Global Burden of Disease 2010 epidemiologic database. The results are on the basis of an analysis of data from worldwide national and regional renal disease registries and detailed systematic literature review for years 1980-2010. Incidence and prevalence estimates of provision of maintenance dialysis from this database were updated using a negative binomial Bayesian metaregression tool for 187 countries. Results indicate substantial growth in utilization of maintenance dialysis in almost all world regions. Changes in population structure, changes in aging, and the worldwide increase in diabetes mellitus and hypertension explain a significant portion, but not all, of the increase because increased dialysis provision also accounts for a portion of the rise. These findings argue for the importance of inclusion of kidney disease among NCD targets for reducing premature death throughout the world.
There is growing emphasis throughout the world on understanding the effects of chronic diseases on population health. Recent advances in treating and preventing communicable diseases coupled with the dramatic rise in the prevalence of diabetes and hypertension have initiated a shift in focus to the relationship between NCDs and morbidity, most recently in developing regions of the world. [1] [2] [3] [4] This is exemplified by the United Nations 2012 Summit 2025 Initiative, which focuses on decreasing the burden of premature mortality to NCDs by 25% by year 2025.
The recent publication of the 2010 Global Burden of Disease Study (GBD) offers a systematic analysis of the contribution of disease and injury to morbidity and early mortality throughout the world. 1 The 2010 GBD is the first edition to include CKD among the chronic diseases assessed and ranks it as the 18th most common cause of death, a substantial increase from its 27th ranking two decades before. 1 These rankings illustrate the significant and increasing effect of CKD on global health.
The 2010 GBD makes it now possible for the first time to calculate the change in prevalence and incidence of provision of maintenance dialysis for 187 countries from 1990 to 2010. These estimates provide timely information and are highly relevant for countries striving to develop programs and strategies for addressing the needs of a quickly growing population of individuals that require the costly medical intervention of RRT. 5, 6 
GLOBAL BURDEN OF MAINTENANCE DIALYSIS
In 2010, throughout the world, we have estimated 284 individuals per million population (pmp) to be undergoing maintenance dialysis (concise methods are included in Supplemental Appendix 1). In 2010, .60 countries provided universal access to maintenance dialysis (Supplemental Table 1 ). These countries accounted for 70% of prevalent maintenance dialysis and 60% of incident dialysis population worldwide (Figures 1 and 2 , Tables 1  and 2 ).
Global Prevalence and Incidence
The global prevalence of maintenance dialysis has increased 1.7 times from 165 pmp patients in 1990 to 284 pmp in 2010. There was a 170% increase in prevalence of patients treated with maintenance dialysis in countries that provided universal access and a 154% increase in the last two decades for countries still working toward universal access ( Table 1) .
The rise in incidence was even more notable. The global incidence more than doubled from 44 pmp incidents in 1990 to 93 pmp in 2010 (Table 2) . When stratifying the world by universal and partial dialysis provision, the percent change in incidence for both men and women was approximately 250% among countries that provided universal access and approximately 180% among countries with partial access ( Table 2) .
The strongest contributor to a larger increase in incidence rate than prevalence is the continued expansion of programs that have recently granted universal or partial access to maintenance dialysis in low-and middle-income countries. In contrast, recent data for developed nations, such as the United States and Western Europe, actually demonstrate a stabilizing trajectory of dialysis initiation in recent years. 7, 8 Furthermore, in some countries, many patients are offered maintenance dialysis only as a bridge to kidney transplantation; this, in turn, could explain the higher increase in incidence rates when compared with the change in prevalence. Although mortality rates for patients undergoing maintenance dialysis have decreased, mortality is still significantly higher among dialysis patients when compared with the general population, which would also affect the prevalence over the incidence. 7, 9, 10 Patterns of Change: Geography and Population Structure Assessing patterns of change at a more granular geographic level allows for identification of regions where dramatic change has occurred and other parts of the world where provision of maintenance dialysis has remained stable during the last two decades. North America and Pacific Asian regions had the highest prevalence for maintenance dialysis in both 1990 and 2010, followed by world regions of Europe, Australasia, and portions of Latin America (Figure 1 ). The incidence of provision of maintenance dialysis has followed a similar geographic pattern over time (Figure 2 ). World regions with the consistently lowest estimates include Sub-Saharan Africa and South and Central Asia.
Access to Maintenance Dialysis in Developing Nations
The incidence and prevalence of maintenance dialysis are not equivalent to the burden of ESRD. In many countries in Africa and South Asia, chronic comorbidities contribute to the societal burden of ESRD as also infections such as malaria, schistosomiasis, HIV, and chronic hepatitis. [11] [12] [13] [14] Hence, there is likely a large, untreated burden of ESRD within these regions. 15 These countries face the difficult task of allocating adequate resources for the care of this condition from the large economic strain likely to be imposed by universal provision of maintenance dialysis. 14, 16 The resultant rationing of maintenance dialysis often selects against the impoverished and socially marginalized groups, such as the elderly and chronically infirm, sections of society known to generally have higher rates of CKD. [16] [17] [18] [19] A study of .2000 patients with ESRD in South Africa between 1988 and 2003 revealed that more than half of these patients were not offered dialysis secondary to rationing of RRT. Factors that weighed into the decision to provide dialysis centered on patient access to transportation, degree of comorbidity, and social stability. 20 Therefore, this continued depressed activity within these countries indicates continued limited regional ability to provide RRT rather than a lack of disease burden.
Population Structure
To assess the effect of changes in population structure over time on the burden of treated ESRD, we modeled projected estimates of the prevalence expected if all contributing factors aside from population growth and aging remained constant (Table 1) . Within countries with universal dialysis access in 2010, population growth and aging should have contributed to a 41% increase in prevalent dialysis and a 55% increase among nations with limited dialysis access. Countries with universal access sustained a growth rate of 114% over and above the projected 41% increase, whereas countries with limited access sustained a growth rate of 99% over and above growth anticipated secondary to changes in population structure. These data indicate that although changes in population structure over time play an important role in explaining the dramatic increase in maintenance dialysis throughout the world, this is only a partial explanation.
Within low-income countries, general improved health conditions, such as prevalence of childhood malnutrition, water purity, sanitation, and improved treatment of infectious diseases (e.g., HIV), 21, 22 have contributed to more stable population growth and aging, as indicated by population-based ESRD estimates for these regions (Figure 3 ). [21] [22] [23] The seemingly enormous growth rate in provision of maintenance dialysis above population estimates for these regions should be interpreted with caution (Figure 3) . Regions in Sub-Saharan Africa likely experienced such a growth rate because maintenance dialysis in 1990 was largely nonexistent. In comparison, there has been measurable growth in Central Latin America and Eastern Europe over the last two decades by making significant progress toward increasing dialysis access to substantial portions of the population (Figure 4 ).
Factors for Change: Population Burden of Diabetes Mellitus and Hypertension
There is a robust literature evidencing the increase in diabetes mellitus and hypertension throughout the world, thought secondary to increasing life span, westernization of diet, and the rising tide of obesity and consequent metabolic syndrome. 1, 3, [24] [25] [26] [27] [28] [29] [30] [31] Because diabetes and hypertension are leading causes of ESRD, we determined the contribution of the global rise in these diseases to the rise in prevalence and incidence of maintenance dialysis (Figures 4 and 5) . Results among countries providing partial versus universal dialysis were remarkably similar. We estimated an anticipated growth of approximately 50% in maintenance dialysis patients secondary to diabetes within the general population. Within countries providing universal dialysis access, there was a total increase of 184% and a 188% increase among countries providing partial dialysis access (Tables 3 and 4) . A similar pattern emerged when assessing the increasing burden of hypertension among the general population relative to the growth in maintenance dialysis (Table 4 ). These percentages illustrate that even though the growth of diabetes mellitus and hypertension within the global population plays a large role in the increasing burden of maintenance dialysis, these drivers also do not explain the total rise in rates. The greatest contributor to markedly increased rates of dialysis provision remains the expansion of or governmental support for dialysis programs.
Patterns of Growth: Sex Differences
Sex imbalances in kidney transplantation are well described within the literature, where women are more often known to serve as living donors, whereas men are more likely to be in receipt of kidney transplants. [32] [33] [34] [35] Sex imbalances in the provision of maintenance dialysis are less well described. In limited-resource countries, the sex differences in provision of maintenance dialysis are similar to that for kidney transplantation, with a higher incidence in men than in women. Other factors that may play a role in sex imbalances within resource-limited settings may involve prioritization of men in patriarchal societies and family prioritization of men on the basis of earning potential.
Our analysis indicates that at the global level, in both years 1990 and 2010, men were in greater receipt of maintenance dialysis than women, but dialysis rates for women increased more than men (Table 1) . At the regional level, in 2010, men were in receipt of dialysis to a greater degree than women in all world regions except tropical Latin America, with most notable differences in regions of Australasia, South Asia, and Oceania ( Figure 6 ). These results indicate that although social structures and limited resources likely play a role, there may also be a biologic explanation for sex disparities because there is a higher incidence of maintenance dialysis in men in nearly all societies.
Drivers of ESRD Burden: CKD Detection, Progression, and Death Within the last decade, advances in detection of CKD through widespread implementation of creatinine and GFR measurements have enhanced our ability to detect kidney disease. 36 Specifically, the conceptual model of CKD developed in 2002 by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative has aided our ability to quantify the burden of various stages of CKD and evaluate risk factors and outcomes for the CKD population. Such advances may have had a complex effect on ESRD burden. First, detecting earlier stage CKD allows for time to determine possible etiologies and factors contributing to CKD progression that has the potential to decrease the societal burden of ESRD. Alternatively, detecting later-stage CKD allows for time to prepare for initiation of maintenance dialysis before death. This increased ability to detect CKD at earlier stages and monitor disease progression (subsequently discussed) has possibly contributed to the growth in the ESRD population between 1990 and 2010.
CKD Progression
Understanding risk factors for CKD progression is pivotal to understanding drivers for perspective ESRD increase and for targeting ways in which risk factors for incidence and disease progression can be altered. 37 Although certain determinants of CKD progression are unalterable, such as age, sex, race, and in some circumstances, CKD etiology, some interventions have the potential to affect the rate of progression. 37 As previously stated, diabetes mellitus and hypertension have become the leading drivers for the growing ESRD population within high-, middle-, and low-income countries. Numerous studies indicate the benefit of glucose control and BP control on delaying progression of CKD. [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] These facts highlight the importance of early CKD detection to allow for time to implement such diseasealtering strategies.
Other contributors to CKD progression include episodes of AKI, which is hypothesized to initiate an inflammatory response that continues after the AKI episode has resolved. [48] [49] [50] Causes of AKI vary geographically. The causes for AKI in the developed world regions include imagining contrast, surgery, toxicity from medications, critical illness, and complications to chronic diseases, such as cardiac and liver disease. [51] [52] [53] Within developing world regions, causes can include toxicity from herbal treatments and complications during perinatal events. [54] [55] [56] Again, the relationship between AKI episodes and CKD progression highlights the importance of early CKD detection to increase the likelihood of protecting remaining kidney function from such events.
Within the last decade, evidence for the relationship between CKD and cardiovascular (CV) events highlights the importance of treatment of modifiable CV risk factors within this population, such as lipid management and smoking cessation. 7, 57, 58 Of concern are studies indicating that among patients with CKD, such targets are often not met. 59 7 Other countries have performed similar estimations of projected ESRD growth. 64, 65 By 2020, it is estimated that Greece's ESRD prevalent population will grow to 15,147, with an annual incident increase of 2%. 65 The projected growth of ESRD has also been modeled for Australia, which anticipates a 29% growth in the ESRD population by 2020. This growth is projected to require an average annual RRT per capita expenditure increase of 16%. 64 
Economic Effect of Provision of Maintenance Dialysis
Considering the economic implications of growth in the maintenance dialysis population throughout the world, we have modeled the percentage of total health care expenditure that would need to be allocated to the provision of maintenance dialysis for a portion of the national prevalent CKD stage 5 population under two different scenarios. The first considers 2010 costs for maintenance dialysis for the prevalent population using Thailand's 2010 spending adjusted for national gross domestic product ( Figure 7 ). The second considers the estimated annual per capita spending in the United States for hemodialysis patients in 2010 (Figure 8 ). When using the Thailand's reimbursement rate for peritoneal dialysis, our results illustrate that of the 14 countries with .1% of the total health care expenditure allocated to maintenance dialysis, ten of these countries are located in Asia and North Africa/ Middle East regions (Figures 7 and 8 ).
Applying Thailand's peritoneal dialysis reimbursement rate, all countries ranged between 0.1% and 3.4% of total health care expenditure attributed to maintenance dialysis, except for Suriname with 47%
(not shown in Figures 7 and 8 ). Using the per capita reimbursement for hemodialysis patients, world countries ranged from 0.2% to 4% of total health care expenditure in 2010 (Figure 8 ). The results of this analysis should be interpreted with caution because it assumes care delivery comparable with the referent country (i.e., United States, Thailand). What this analysis illustrates is that there are regional patterns, and regions with high prevalent ESRD burden and high rates of health care spending are most likely to be heavily affected financially by further increasing rates of treated ESRD.
Addressing the Burden: Dialysis Modalities, Transplant, and CKD Screening Dialysis Modalities Alleviating the expected increase in the global economic burden from the growth in the prevalent ESRD population will necessitate capitalizing on all forms of treatment beyond in-center hemodialysis.Withinhigh-and middle-incomecountries, home-based RRTs, such as peritoneal dialysis and home hemodialysis, are feasible and defray the substantial costs of infrastructure maintenance and staffing and offer patient autonomy. [66] [67] [68] [69] Within the United States, there has been a 35% increase in home-based RRT between 2002 and 2012, most of which were peritoneal dialysis. 7 Thailand has a universal health care structure meant to provide health coverage to individuals not covered by existing systems, such as social security. Maintenance dialysis was incorporated into universal coverage in 2007. 70 This program prioritizes initiation with peritoneal dialysis and transition to hemodialysis for those deemed unsuitable for peritoneal dialysis. 7 0 Within developing countries, the financial gains of homebased therapies are less clear. 71 Costs and supplies vary on the basis of regional production of solutions for peritoneal dialysis versus importation; therefore, home-based treatments, such as peritoneal dialysis, may not always be more cost-effective. 71 Within such regions, country-level analyses are needed to determine unique barriers for broad-based provision of RRT for the largest segment of the population at the lowest cost.
Renal Transplantation
Renal transplantation offers clear benefits in terms of quality of life and survival and societal economic benefit. Within the last two decades, advances in immunosuppression have led to improved allograft and patient survival. Within high-income countries, advances in ability to transplant across blood groups, paired kidney donation programs, and preemptive renal transplants have collectively increased rates of renal transplantations. 72 However, resource scarcity limits this treatment modality in both high-and low-income regions. Lowincome countries experience added limitations of infrastructure and shortages of surgical expertise. Resultant transplant tourism and organ trafficking that occur in such settings to address deceased donor organ shortages often target the most impoverished members of such populations. 72 Further, financial constraints secondary to lack of governmental financial support for transplant programs lead to early discontinuation of immunosuppressive therapy, leading to premature graft loss. 73 
Population-level CKD Screening
The most effective prevention against further ESRD growth is CKD prevention. 74 Systematic population-based CKD screening should be considered by societies around the world to determine the portion of the population at risk versus those affected by CKD. [75] [76] [77] Currently, few societies implement systematic screening for adults unless they have risk factors, such as diabetes mellitus or advanced age. 78 Considering that early-to moderate stage CKD is relatively asymptomatic, screening has multiple advantages. First, screening identifies individuals with CKD that might not be diagnosed until late stage when symptoms manifest, but when options for retarding progression are few. Second, screening for CKD may facilitate detection of undiagnosed diabetes, hypertension, and CV disease. [79] [80] [81] [82] Third, as CV risk factors are suboptimally controlled within the CKD population, screening and detection of CKD allow for better treatment of CV risk factors. Fourth, identification of the portion of the population with kidney disease further delineates the remaining population that could serve as potential living kidney donors. When assessing the wide variation in the treatment of ESRD in Asia, such as differences between India, Pakistan, and China compared with Taiwan, one can deduce the magnitude of burden of untreated ESRD within densely populated regions of the world (Figures 1 and 2 ). It will be challenging to plan to address the anticipated increase in the burden of ESRD solely with renal transplantation and maintenance dialysis, for both high-and low-income world regions. Systematic early CKD detection combined with detection and prevention of drivers, such as diabetes, hypertension, and CV disease, are critical.
Long-reaching Effect: ESRD and the Global Burden of NCDs
The recent 2012 United Nations Summit held to address the global burden of NCDs concluded with the formation of the 2025 Initiative. 83 This initiative resolves to decrease the global burden of NCDs by 25% by 2025. Although an important initiative that focuses global attention on the leading causes of premature mortality, the initiative focuses specifically on diabetes, cancer, CV disease, respiratory diseases, and neurologic disease. In light of the rising burden of both pre-ESRD CKD and ESRD, omission of CKD as an independent cause of premature life loss will inevitably detract from the overall success of the initiative. Furthermore, with success in decreasing the burden of these specifically targeted NCDs, the consequent increased survival may potentially cause a further increase in the prevalence of CKD globally. As noted, our estimates illustrate such a continued rise in both CKD and ESRD, as survival within the CKD population also improves, and countries expand their ability to provide RRT to the ESRD population. differed from the national denominator used in this analysis. Second, our regression analysis estimates epidemiologic parameters for 1990 and 2010 on the basis of data gathered from available time points closest to those years.
SUMMARY
To our knowledge, this study is the first analysis of sufficient scope to describe the global prevalence and incidence of maintenance dialysis treatment for ESRD.
Comparing 1990 and 2010, there has been a general trend of substantially increased provision of maintenance dialysis in both men and women above what was anticipated secondary to population growth, aging, and increase in prevalence of diabetes and hypertension, with most notable increases occurring in parts of Australasia, Asia, North America, and Western Europe. Oceania and portions of Sub-Saharan Africa have maintained a low prevalence of maintenance dialysis when compared with most of the world; however, growth in these regions has occurred. With the exception of tropical Latin America, men were more likely to receive dialysis than women; however, the global change in prevalence and incidence for treated women in the last two decades has surpassed that of men. Maintenance dialysis is a costly treatment for ESRD with economic implications for both high-and low-income world regions. Within high-income regions of the world, efforts are needed to address drivers of increase in ESRD, such as obesity, diabetes mellitus, and hypertension. Research is needed to further evaluate reasons for sex differences within the ESRD population. Within regions of the world with emerging economies, expansion of dialysis to larger portions of the population is urgently needed, especially within SubSaharan Africa and Oceania, to save lives and deter the difficult task of patient selection when resources are limited.
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